summary
Introduced
01/20/2026
01/20/2026
In Committee
02/02/2026
02/02/2026
Crossed Over
02/24/2026
02/24/2026
Passed
Dead
Introduced Session
Fifty-seventh Legislature - Second Regular Session (2026)
Bill Summary
AN ACT Amending title 36, chapter 27, article 2, Arizona Revised Statutes, by adding section 36-2517.03; relating to the Arizona state board of pharmacy.
AI Summary
This bill, concerning approved medications and prescription authority in Arizona, establishes that any compound, mixture, or preparation approved by the United States Food and Drug Administration (FDA) and subsequently scheduled or rescheduled by the United States Drug Enforcement Administration (DEA) will automatically be assigned the identical schedule under Arizona law, without requiring further action from the Arizona State Board of Pharmacy. Furthermore, if such an FDA-approved and DEA-scheduled substance is placed on a schedule other than Schedule I of the controlled substances act, it will be considered a controlled substance in Arizona and will be eligible for prescription within the state. This aims to streamline the process of incorporating federally regulated medications into Arizona's controlled substance framework.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
House Health & Human Services (14:00:00 3/9/2026 HHR 4) (on 03/09/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://apps.azleg.gov/BillStatus/BillOverview/84115 |
| BillText | https://www.azleg.gov/legtext/57leg/2r/bills/sb1188s.htm |
| Analysis - SENATE FACT SHEET: 01/26/2026 HHS | https://apps.azleg.gov/BillStatus/GetDocumentPdf/534820 |
| BillText | https://www.azleg.gov/legtext/57leg/2r/bills/sb1188p.htm |
Loading...